Centracare Clinic
Centracare Clinic was paid $20.93M by Medicaid between Jan 2018 and Dec 2024, across 144 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 18% of everything it billed.
ST CLOUD, MN 56303
Next to other Durable Medical Equipment & Medical Supplies providers in Minnesota
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 100,742 | $1.31M | |
| 2019 | 110,164 | $3.75M | |
| 2020 | 94,972 | $2.96M | |
| 2021 | 95,044 | $3.65M | |
| 2022 | 102,666 | $3.44M | |
| 2023 | 99,378 | $3.03M | |
| 2024incomplete | 90,096 | $2.78M |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 18% | 70,463 | 66,071 | $3.69M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 14% | 39,587 | 37,397 | $2.83M |
| X5622 | 8.5% | 20,780 | 19,392 | $1.79M | |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 7.1% | 22,474 | 22,074 | $1.48M |
| S0302 | Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) | 7.0% | 64,845 | 61,809 | $1.46M |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 6.2% | 25,693 | 22,919 | $1.29M |
| T1013 | Sign language or oral interpretive services, per 15 minutes | 5.5% | 29,382 | 25,629 | $1.14M |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 4.2% | 14,044 | 13,774 | $877K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 3.6% | 23,605 | 23,013 | $752K |
| 59400 | Routine obstetric care including antepartum care, vaginal delivery, and postpartum care | 3.1% | 728 | 710 | $649K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 2.3% | 31,145 | 30,193 | $481K |
| 76819 | Fetal biophysical profile; without non-stress testing | 2.2% | 12,732 | 5,522 | $470K |
132 more codes
| 90472 | Immunization administration, each additional vaccine (list separately) | 1.8% | 20,337 | $382K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | 1.7% | 8,137 | $366K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 1.4% | 4,521 | $295K |
| 99188 | 1.1% | 31,031 | $240K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | 1.1% | 5,651 | $222K |
| 92551 | <1% | 28,925 | $162K | |
| 96127 | <1% | 42,007 | $144K | |
| 99244 | Office or other outpatient consultation, moderate to high complexity | <1% | 1,153 | $138K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 1,967 | $121K |
| H1001 | Prenatal care, at-risk enhanced service; antepartum management | <1% | 2,209 | $121K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 14,325 | $101K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 877 | $94K |
| 99243 | <1% | 1,069 | $91K | |
| 76830 | Ultrasound, transvaginal | <1% | 1,894 | $86K |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | <1% | 1,857 | $83K |
| 90715 | <1% | 4,028 | $80K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 2,373 | $69K |
| 97803 | <1% | 1,781 | $66K | |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 920 | $62K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 898 | $61K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 576 | $61K |
| 90832 | Psychotherapy session, about 30 minutes | <1% | 1,181 | $58K |
| 59425 | <1% | 165 | $58K | |
| 90686 | <1% | 24,251 | $54K | |
| J7307 | Etonogestrel (contraceptive) implant system, including implant and supplies | <1% | 66 | $44K |
| 76801 | <1% | 874 | $42K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 1,396 | $37K |
| 59510 | <1% | 43 | $36K | |
| 91322 | <1% | 354 | $33K | |
| 99173 | <1% | 27,443 | $32K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,985 | $31K |
| 90480 | <1% | 1,055 | $31K | |
| 90473 | <1% | 2,626 | $31K | |
| 96161 | <1% | 17,403 | $28K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 713 | $27K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 2,423 | $26K |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | <1% | 381 | $23K |
| 59025 | Fetal non-stress test | <1% | 668 | $20K |
| 90847 | Family psychotherapy with the patient present, 50 minutes | <1% | 299 | $19K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 437 | $19K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 585 | $19K |
| 90651 | <1% | 1,764 | $18K | |
| 0072A | <1% | 388 | $16K | |
| 94010 | <1% | 950 | $15K | |
| 99245 | <1% | 102 | $14K | |
| 97802 | <1% | 197 | $13K | |
| 76818 | <1% | 206 | $13K | |
| 58300 | <1% | 202 | $13K | |
| J7298 | Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg | <1% | 24 | $12K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 504 | $12K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 498 | $11K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 741 | $11K |
| 74018 | <1% | 695 | $11K | |
| 0071A | <1% | 242 | $10K | |
| 0002A | <1% | 238 | $10K | |
| 99417 | Prolong home eval add 15m | <1% | 155 | $9K |
| 96040 | <1% | 163 | $7K | |
| 90677 | <1% | 2,248 | $7K | |
| 0001A | <1% | 143 | $6K | |
| 76857 | <1% | 306 | $5K | |
| 87480 | <1% | 437 | $5K | |
| 87510 | <1% | 437 | $5K | |
| 87660 | <1% | 437 | $5K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 444 | $5K |
| 99383 | <1% | 58 | $5K | |
| 90656 | <1% | 1,814 | $5K | |
| 99382 | <1% | 53 | $4K | |
| 0052A | <1% | 97 | $4K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 2,145 | $4K |
| 86780 | <1% | 330 | $3K | |
| 90694 | <1% | 56 | $3K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 152 | $3K |
| 77080 | <1% | 154 | $3K | |
| 99242 | <1% | 42 | $3K | |
| G0008 | Administration of influenza virus vaccine | <1% | 313 | $3K |
| 59514 | <1% | 31 | $2K | |
| 83655 | <1% | 301 | $2K | |
| 87070 | <1% | 343 | $2K | |
| 90653 | <1% | 24 | $2K | |
| 0081A | <1% | 50 | $2K | |
| 58301 | <1% | 25 | $2K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 227 | $2K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 291 | $2K |
| 59430 | <1% | 16 | $2K | |
| 11981 | <1% | 39 | $2K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 15 | $2K |
| 87150 | <1% | 42 | $1K | |
| 96380 | <1% | 90 | $1K | |
| 85018 | <1% | 694 | $1K | |
| A4627 | Spacer, bag or reservoir, with or without mask, for use with metered dose inhaler | <1% | 57 | $1K |
| 11982 | <1% | 12 | $1K | |
| 91321 | <1% | 329 | $992.49 | |
| 90670 | <1% | 12,959 | $933.04 | |
| 90620 | <1% | 77 | $906.94 | |
| 94060 | <1% | 54 | $875.76 | |
| 36416 | <1% | 428 | $686.48 | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 57 | $656.73 |
| 98968 | <1% | 23 | $605.46 | |
| 90707 | <1% | 1,352 | $558.85 | |
| 0051A | <1% | 13 | $530.50 | |
| 82950 | <1% | 129 | $497.11 | |
| 0124A | <1% | 12 | $448.71 | |
| 69210 | <1% | 12 | $412.71 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 15 | $390.62 |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 44 | $367.22 |
| 69209 | <1% | 27 | $345.75 | |
| H1000 | Prenatal care, at-risk assessment | <1% | 69 | $340.52 |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 12 | $285.36 |
| 84702 | <1% | 18 | $267.48 | |
| 90681 | <1% | 5,642 | $239.84 | |
| 90723 | <1% | 11,301 | $230.56 | |
| 85027 | <1% | 24 | $162.09 | |
| 81001 | <1% | 46 | $162.07 | |
| 90716 | <1% | 1,819 | $132.88 | |
| 90734 | <1% | 1,277 | $126.51 | |
| 86850 | <1% | 12 | $106.37 | |
| 90647 | <1% | 10,638 | $87.58 | |
| 90633 | <1% | 5,739 | $67.78 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 254 | $17.19 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 20 | $14.14 |
| 90696 | <1% | 1,105 | $0.27 | |
| 90700 | <1% | 1,347 | $0.24 | |
| 90710 | <1% | 866 | $0.24 | |
| 90381 | 0% | 45 | $0.00 | |
| 88142 | 0% | 63 | $0.00 | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 0% | 14 | $0.00 |
| 95117 | 0% | 25 | $0.00 | |
| 87430 | 0% | 49 | $0.00 | |
| 90685 | 0% | 1,717 | $0.00 | |
| 90672 | 0% | 35 | $0.00 | |
| 90713 | 0% | 28 | $0.00 | |
| 17110 | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
| Provider | Location | Paid |
|---|---|---|
| ST. Cloud Hospital | Saint Cloud, MN | $53.43M |
| Centracare Clinic | St Cloud, MN | $19.28M |
| Centracare Health System | Big Lake, MN | $12.82M |
| Carris Health LLC | Willmar, MN | $12.39M |
| Centracare Health Systems | Saint Cloud, MN | $9.41M |
| Centracare Health System | Saint Cloud, MN | $9.06M |
| Carris Health LLC | Willmar, MN | $8.27M |
| Centracare Clinic | Saint Cloud, MN | $6.96M |
| Centracare Health System - Long Prairie | Long Prairie, MN | $6.86M |
| Centracare Health System-Nr LLC | Monticello, MN | $6.73M |
| Centracare Clinic | Sartell, MN | $6.11M |
| ST. Cloud Hospital | Saint Cloud, MN | $5.16M |
| Carris Health - Redwood LLC | Redwood Falls, MN | $4.74M |
| ST. Cloud Hospital | St Cloud, MN | $4.44M |
| Centracare Health System - Sauk Centre | Sauk Centre, MN | $4.19M |
| Centracare Health System - Melrose | Melrose, MN | $4.05M |
| Centracare Clinic | Saint Cloud, MN | $3.58M |
| Centracare Clinic | Saint Cloud, MN | $2.83M |
| Carris Health, LLC | Willmar, MN | $2.82M |
| ST. Cloud Hospital | Sauk Rapids, MN | $2.53M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.